1. Home
  2. East Africa
  3. Uganda

Poor turnout for HIV/AIDS vaccine trials

The Uganda Virus Research Institute (UVRI) on Wednesday said it was optimistic despite the poor turnout of volunteers for phase one of the HIV/AIDS vaccine trials. UVRI said only 10 out of the 50 "expected" volunteers were participating in the trials which began in February. "The response is very slow. We still need 40 volunteers to enrol between now and 2004," URVI's head of immunology, Dr Pontiano Kaleebu, told the UN news service PlusNews. Kaleebu said the initial phase required 50 volunteers between the ages of 18 and 50 to be given four vaccine injections each, over a period of 18 months. "We are hopeful that more volunteers will come forward during the course of 2003," Kaleebu added.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join